arrow
A

Augusto Caraceni

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:69
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pain in Epithelioid Hemangioendothelioma: Development of Disease-Specific Pain Assessment Criteria (PAC-E)

上皮样血管内皮瘤的疼痛:疾病特异性疼痛评估标准(PAC-E)的开发

2026-10-060
OA
Needs and health-related quality of life domains relevant to people in Europe with advanced cancer in need of palliative care: a systematic review of qualitative research

晚期癌症且需要姑息治疗的患者在欧洲的需求与健康相关生活质量领域:一项定性研究的系统综述

2026-02-180
OAAI
EU JOINT ACTION: Integrating Palliative Care in the EU Cancer Agenda: Insights from JANE-2

欧盟联合行动:将姑息治疗纳入欧盟癌症议程:JANE-2的见解

2026-02-130
OAAI
Systemic anticancer therapy during end of life in head and neck squamous cell carcinoma patients. A retrospective single center study.

头颈部鳞状细胞癌患者临终期系统性抗肿瘤治疗。一项回顾性单中心研究。

2025-08-290
OAAI
Denosumab Versus Zoledronic Acid in Metastatic Breast Cancer: A Retrospective Observational Analysis of 24-Dose Regimens on Analgesia and Skeletal-Related Event Prevention.

Denosumab 与 Zoledronic Acid 在转移性乳腺癌中的应用比较:一项关于 24 剂方案在镇痛和骨骼相关事件预防方面的回顾性观察分析。

2025-08-270
OAAI
Evaluating the Involvement of People With Cancer and Informal Caregivers in the Development Process of a New Set of Quality of Life Questionnaires

评估癌症患者和非正式护理人员在新型生活质量问卷开发过程中的参与情况

2025-04-290
OAAI
Psychosocial factors associated with quality of life in cancer patients undergoing treatment: an umbrella review

癌症治疗期间患者生活质量相关的心理社会因素:一项伞状综述

2025-04-050
OA
Systematic review of the needs and health-related quality of life domains relevant to people surviving cancer in Europe

与欧洲癌症幸存者相关的需求和健康相关的生活质量领域的系统评价

2025-01-230
OAAI
Patient Voices: Multimethod Study on the Feasibility of Implementing Electronic Patient-Reported Outcome Measures in a Comprehensive Cancer Center

患者的声音: 在综合癌症中心实施电子患者报告结果测量的可行性的多方法研究

2025-01-220
OA
Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European survey
2024-12-180
OAAI